Cargando…

Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus

BACKGROUND: In this study, we investigated whether serum levels of advanced glycation end products (AGEs) independently correlated with relative muscle strength after adjustment for clinical variables including diabetic peripheral neuropathy in patients with type 2 diabetes. Relative muscle strength...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tsung-Hui, Tsai, Shiow-Chwen, Lin, Hsuan-Wei, Chen, Chiao-Nan, Hwu, Chii-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066950/
https://www.ncbi.nlm.nih.gov/pubmed/35505327
http://dx.doi.org/10.1186/s12902-022-01035-1
_version_ 1784699904323485696
author Wu, Tsung-Hui
Tsai, Shiow-Chwen
Lin, Hsuan-Wei
Chen, Chiao-Nan
Hwu, Chii-Min
author_facet Wu, Tsung-Hui
Tsai, Shiow-Chwen
Lin, Hsuan-Wei
Chen, Chiao-Nan
Hwu, Chii-Min
author_sort Wu, Tsung-Hui
collection PubMed
description BACKGROUND: In this study, we investigated whether serum levels of advanced glycation end products (AGEs) independently correlated with relative muscle strength after adjustment for clinical variables including diabetic peripheral neuropathy in patients with type 2 diabetes. Relative muscle strength was defined as muscle strength (in decinewtons, dN) divided by total muscle mass (in kg). METHODS: We enrolled 152 ambulatory patients with type 2 diabetes. Each participant underwent measurements of muscle strength and total muscle mass. Serum levels of AGEs were determined. The Michigan Neuropathy Screening Instrument Physical Examination (MNSI-PE) was performed to assess diabetic peripheral neuropathy. RESULTS: The participants were divided into three groups on the basis of tertiles of serum AGEs levels. Significant differences were observed among the three groups in relative handgrip strength (71.03 ± 18.22, 63.17 ± 13.82, and 61.47 ± 13.95 dN/kg in the low-tertile, mid-tertile, and high-tertile groups, respectively, P = 0.005). The relative muscle strength of the ankle plantar flexors was higher in the low-tertile group than in the mid-tertile and high-tertile groups (107.60 ± 26.53, 94.97 ± 19.72, and 94.18 ± 16.09 dN/kg in the low-tertile, mid-tertile, and high-tertile groups, respectively, P = 0.002). After adjustment for MNSI-PE score and other clinical variables in partial correlation analysis, the correlations between serum levels of AGEs and the relative muscle strength of handgrip, ankle dorsiflexor, and ankle plantar flexor remained significant. Serum AGEs level was the only variable that remained significantly related to the relative muscle strength of handgrip, ankle dorsiflexor, and ankle plantar flexor when AGEs level, fasting plasma glucose, and glycated hemoglobin (HbA(1c)) were entered into multiple regression models simultaneously. CONCLUSIONS: After adjustment for multiple factors including diabetic peripheral neuropathy, this study demonstrated that increased serum levels of AGEs were independently associated with decreased relative muscle strength in patients with type 2 diabetes. Compared with fasting plasma glucose and HbA(1c), serum level of AGEs is more strongly associated with relative muscle strength.
format Online
Article
Text
id pubmed-9066950
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90669502022-05-04 Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus Wu, Tsung-Hui Tsai, Shiow-Chwen Lin, Hsuan-Wei Chen, Chiao-Nan Hwu, Chii-Min BMC Endocr Disord Research BACKGROUND: In this study, we investigated whether serum levels of advanced glycation end products (AGEs) independently correlated with relative muscle strength after adjustment for clinical variables including diabetic peripheral neuropathy in patients with type 2 diabetes. Relative muscle strength was defined as muscle strength (in decinewtons, dN) divided by total muscle mass (in kg). METHODS: We enrolled 152 ambulatory patients with type 2 diabetes. Each participant underwent measurements of muscle strength and total muscle mass. Serum levels of AGEs were determined. The Michigan Neuropathy Screening Instrument Physical Examination (MNSI-PE) was performed to assess diabetic peripheral neuropathy. RESULTS: The participants were divided into three groups on the basis of tertiles of serum AGEs levels. Significant differences were observed among the three groups in relative handgrip strength (71.03 ± 18.22, 63.17 ± 13.82, and 61.47 ± 13.95 dN/kg in the low-tertile, mid-tertile, and high-tertile groups, respectively, P = 0.005). The relative muscle strength of the ankle plantar flexors was higher in the low-tertile group than in the mid-tertile and high-tertile groups (107.60 ± 26.53, 94.97 ± 19.72, and 94.18 ± 16.09 dN/kg in the low-tertile, mid-tertile, and high-tertile groups, respectively, P = 0.002). After adjustment for MNSI-PE score and other clinical variables in partial correlation analysis, the correlations between serum levels of AGEs and the relative muscle strength of handgrip, ankle dorsiflexor, and ankle plantar flexor remained significant. Serum AGEs level was the only variable that remained significantly related to the relative muscle strength of handgrip, ankle dorsiflexor, and ankle plantar flexor when AGEs level, fasting plasma glucose, and glycated hemoglobin (HbA(1c)) were entered into multiple regression models simultaneously. CONCLUSIONS: After adjustment for multiple factors including diabetic peripheral neuropathy, this study demonstrated that increased serum levels of AGEs were independently associated with decreased relative muscle strength in patients with type 2 diabetes. Compared with fasting plasma glucose and HbA(1c), serum level of AGEs is more strongly associated with relative muscle strength. BioMed Central 2022-05-04 /pmc/articles/PMC9066950/ /pubmed/35505327 http://dx.doi.org/10.1186/s12902-022-01035-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Tsung-Hui
Tsai, Shiow-Chwen
Lin, Hsuan-Wei
Chen, Chiao-Nan
Hwu, Chii-Min
Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_full Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_fullStr Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_full_unstemmed Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_short Increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
title_sort increased serum levels of advanced glycation end products are negatively associated with relative muscle strength in patients with type 2 diabetes mellitus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066950/
https://www.ncbi.nlm.nih.gov/pubmed/35505327
http://dx.doi.org/10.1186/s12902-022-01035-1
work_keys_str_mv AT wutsunghui increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus
AT tsaishiowchwen increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus
AT linhsuanwei increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus
AT chenchiaonan increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus
AT hwuchiimin increasedserumlevelsofadvancedglycationendproductsarenegativelyassociatedwithrelativemusclestrengthinpatientswithtype2diabetesmellitus